Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Vistagen Therapeutics Inc (VTGN)

Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
VTGN DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Vistagen Therapeutics (VTGN) Investors of Securities Class Action Deadline on March 16, 2026 PR Newswire - Sat Feb 21, 6:43AM CST

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options

VTGN : 0.5591 (-5.61%)
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Vistagen Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - VTGN PR Newswire - Thu Feb 19, 6:29PM CST

NEW YORK , Feb. 19, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Vistagen Therapeutics, Inc. ("Vistagen" or the "Company") (NASDAQ: VTGN).  ...

VTGN : 0.5591 (-5.61%)
Shareholders that lost money on Vistagen Therapeutics, Inc.(VTGN) Urged to Join Class Action - Contact The Gross Law Firm to Learn More PR Newswire - Thu Feb 19, 8:00AM CST

NEW YORK , Feb. 19, 2026 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Vistagen Therapeutics, Inc. (NASDAQ: VTGN).

VTGN : 0.5591 (-5.61%)
LEVI & KORSINSKY, LLP: VISTAGEN THERAPEUTICS STOCK DROPS OVER 80% FOLLOWING CLINICAL TRIAL DISCLOSURE -- CLASS ACTION SEEKS DAMAGES FOR INVESTORS PR Newswire - Wed Feb 18, 8:00AM CST

NEW YORK , Feb. 18, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP reminds purchasers of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) securities of the important March 16, 2026 lead plaintiff deadline....

VTGN : 0.5591 (-5.61%)
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire - Tue Feb 17, 12:12PM CST

NEW YORK , Feb. 17, 2026 /PRNewswire/ -- 

VTGN : 0.5591 (-5.61%)
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN PR Newswire - Tue Feb 17, 12:19AM CST

LOS ANGELES , Feb. 17, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Vistagen Therapeutics, Inc. ("Vistagen " or "the Company") (NASDAQ: VTGN ...

VTGN : 0.5591 (-5.61%)
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire - Mon Feb 16, 11:03PM CST

LOS ANGELES , Feb. 17, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vistagen Therapeutics,...

VTGN : 0.5591 (-5.61%)
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire - Fri Feb 13, 12:22AM CST

LOS ANGELES , Feb. 13, 2026 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vistagen Therapeutics,...

VTGN : 0.5591 (-5.61%)
Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN PR Newswire - Fri Feb 13, 12:16AM CST

LOS ANGELES , Feb. 13, 2026 /PRNewswire/ -- The DJS Law Group  reminds investors of a class action lawsuit against Vistagen Therapeutics, Inc. ("Vistagen " or "the Company") (NASDAQ: VTGN...

VTGN : 0.5591 (-5.61%)
VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit PR Newswire - Fri Feb 13, 12:13AM CST

NEW YORK , Feb. 13, 2026 /PRNewswire/ --

VTGN : 0.5591 (-5.61%)

Barchart Exclusives

Most Retail Investors Think They’re Investing: They’re Actually Trading The Market Barchart - Sat Feb 21, 10:10AM CST
Most retail investors think they’re investing in businesses, but they’re actually reacting to market noise instead of analyzing incentives, capital allocation, and structural change. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot